News | Remote Viewing Systems | August 07, 2025

TechLive is a vendor-agnostic integrated solution enabling remote scanning of MR, CT, PET/CT, and Ultrasound procedures. 

DeepHealth Secures FDA Clearance for Remote Scanning Solution

August 7, 2025 — DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc., announced it has received FDA 510(k) clearance for TechLive – a remote scanning solution enabling centralized operation and supervision of MR, CT, PET/CT, and ultrasound procedures. Amid tech labor shortages and inflationary wage pressure, TechLive empowers technologists to scan for multiple locations, enables improved operational efficiency, extends center operating hours and enhances access to complex procedures. More than 300 of RadNet’s MR, CT, PET/CT, and ultrasound systems are now connected with DeepHealth’s TechLive, resulting in increased patient throughput and improved quality through remotely matching expert staff with complex modalities in real-time.  

Over the past decade, radiology workloads have steadily increased, while the number of qualified technologists has not grown proportionally. In a pilot deployment at 64 locations inside of RadNet’s New York area facilities, TechLive significantly contributed to a 42% decrease in MRI room closure hours during the second quarter of 2025 compared with the same period in 2024, allowing more patients to receive timely scans.

Additionally, as a result of the remote expert involvement during the same pilot deployment, TechLive contributed to an increase in complex procedures. Furthermore, in extending remote scanning capabilities to Ultrasound, TechLive is enabling experienced senior sonographers and physicians to remotely guide technologists on-site through complex cases in a modality that is heavily dependent upon real-time, operator expertise.  

“TechLive represents a paradigm shift in how we approach imaging operations,” said Sham Sokka, PhD, Chief Operating and Technology Officer at DeepHealth. “By enabling real-time remote expertise, we are not only addressing today’s staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities. This FDA clearance validates DeepHealth’s vision of a connected imaging ecosystem that scales human expertise beyond physical boundaries.” 

Go to https://deephealth.com  for more information.


Related Content

News | Cardiac Imaging

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...

Time October 27, 2025
arrow
News | Endoscopes

Oct. 22, 2025 — Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 ...

Time October 23, 2025
arrow
News | X-Ray

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the ...

Time October 22, 2025
arrow
News | Computed Tomography (CT)

Oct. 9, 2025 — Harrison.ai has received three FDA Breakthrough Device Designations for CT imaging solutions, further ...

Time October 21, 2025
arrow
News | Contrast Media

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive ...

Time October 21, 2025
arrow
News | Artificial Intelligence

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care ...

Time October 20, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound ...

Time October 16, 2025
arrow
News | Women's Health

Oct. 3, 2025 — IceCure Medical Ltd., developer of minimally-invasive cryoablation technology that destroys tumors by ...

Time October 06, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

September 24, 2025—According to the American Journal of Roentgenology (AJR), MRI can reliably identify lateral meniscal ...

Time October 03, 2025
arrow
News | Radiopharmaceuticals and Tracers

Oct. 01, 2025 – Nuclidium AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time October 02, 2025
arrow
Subscribe Now